Nigel McCracken
Chief Operating Officer en VIRAX BIOLABS GROUP LIMITED .
Cargos activos de Nigel McCracken
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| VIRAX BIOLABS GROUP LIMITED | Chief Operating Officer | 01/09/2023 | - |
Historial de carrera de Nigel McCracken
Antiguos cargos conocidos de Nigel McCracken.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| BERGENBIO ASA | Chief Tech/Sci/R&D Officer | 01/01/2021 | 01/09/2023 |
Debiopharm International SA
 Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | Director/Board Member | 01/09/2014 | 01/04/2019 |
| Corporate Officer/Principal | 01/09/2014 | 01/04/2019 | |
| NUCANA PLC | Chief Operating Officer | - | - |
Formación de Nigel McCracken.
| University of Strathclyde | Undergraduate Degree |
| King's College London | Graduate Degree |
Estadísticas
Internacional
| Reino Unido | 5 |
| Suiza | 2 |
| Noruega | 2 |
Operativa
| Chief Operating Officer | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Director/Board Member | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| BERGENBIO ASA | Health Technology |
| NUCANA PLC | Health Technology |
| VIRAX BIOLABS GROUP LIMITED | Finance |
| Empresas privadas | 1 |
|---|---|
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | Health Technology |
- Bolsa de valores
- Insiders
- Nigel McCracken
- Experiencia
